Centene Corp (CNC) 69.08 $CNC Humana Beats Q2 Earnings,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Centene Corp (CNC) 69.08 $CNC

Humana Beats Q2 Earnings, Falls Y/Y on Poor Retail Segment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 39 mins ago
Humana Inc.'s (HUM) second-quarter 2015 operating earnings came in at $1.67 per share surpassing the Zacks Consensus Estimate of $1.63.
CNC: 69.08 (-0.59), UNH: 121.36 (-0.16), AET: 111.45 (-0.86), HUM: 182.69 (-1.83)


Insurer Anthem hikes 2015 forecast, 2Q earnings climb
By TOM MURPHY - AP - Wed Jul 29, 9:15AM CDT
Anthem has pumped up its 2015 forecast again after earnings jumped more than 17 percent in its most recent quarter, helped by a surge in government money.
CNC: 69.08 (-0.59), CI: 145.90 (+0.03), ANTM: 154.45 (+0.25), ANTX: 50.81 (+0.10), AET: 111.45 (-0.86), HNT: 65.95 (-0.09), HUM: 182.69 (-1.83)

Centene (CNC) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Tue Jul 28, 1:41PM CDT
The following Centene (CNC) conference call took place on July 28, 2015, 08:30 AM ET. This is a transcript of that earnings call:
CNC: 69.08 (-0.59)

Centene beats 2Q profit forecasts
Automated Insights - Tue Jul 28, 5:18AM CDT
ST LOUIS (AP) _ Centene Corp. (CNC) on Tuesday reported second-quarter earnings of $88 million.
CNC: 69.08 (-0.59)

Centene Corporation Reports 2015 Second Quarter Results
PR Newswire - Tue Jul 28, 5:00AM CDT
Centene Corporation (NYSE: CNC) today announced its financial results for the quarter ended June 30, 2015. The following discussions, with the exception of cash flow information, are in the context of continuing operations.
CNC: 69.08 (-0.59)

Upgrade Alert for Centene (CNC)
Comtex SmarTrend(R) - Mon Jul 27, 8:04AM CDT
Centene (NYSE:CNC) was upgraded from Neutral to Buy at UBS today. The stock closed yesterday at $69.04 on volume of 1.8 million shares, below average daily volume of 2.2 million. In the past 52 weeks, shares of Centene have traded between a low of $35.49 and a high of $83.00 and closed yesterday at $69.04, which is 95% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 1.3% while the 50-day MA has advanced 0.7%.
CNC: 69.08 (-0.59)

Anthem To Buy Cigna As Insurers Rush To Consolidate
at Investor's Business Daily - Fri Jul 24, 7:34AM CDT
Anthem (ANTM) confirmed Friday that it will buy Cigna (CI) for $48 billion, as the health care industry continues its recent consolidation. Anthem will pay $188 a share, with Cigna shareholders receiving $103.40 in cash and 0.5152 Anthem shares for...
CNC: 69.08 (-0.59), CI: 145.90 (+0.03), ANTM: 154.45 (+0.25), UNH: 121.36 (-0.16), AET: 111.45 (-0.86), HNT: 65.95 (-0.09), HUM: 182.69 (-1.83)

And Then There Were 3? Anthem Near $48 Bil Cigna Deal
at Investor's Business Daily - Wed Jul 22, 10:27PM CDT
Anthem (ANTM) will announce a deal to buy Cigna (CI) for about $48 billion, or $187 a share as soon as Thursday, according to a variety of reports. Along with other mergers, the managed care industry on the road to shrinking to three giants from five...
CNC: 69.08 (-0.59), CI: 145.90 (+0.03), ANTM: 154.45 (+0.25), UNH: 121.36 (-0.16), AET: 111.45 (-0.86), HNT: 65.95 (-0.09), HUM: 182.69 (-1.83)

Humana (HUM) Boosts ACO Relationship with Iora Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 22, 1:35PM CDT
In an attempt to strengthen their Accountable Care arrangement, Humana, Inc. (HUM) and Iora Health will establish seven primary care practices in four markets across Arizona, Colorado and Washington.
CNC: 69.08 (-0.59), ANTM: 154.45 (+0.25), SEM: 14.89 (+0.03), HUM: 182.69 (-1.83)

Molina Scoffs At Merger Mania, Keeps Growing Medicaid
at Investor's Business Daily - Wed Jul 22, 12:58PM CDT
As consolidation fever grips the managed care industry, Molina Healthcare (MOH) prefers to "stick to our knitting," as chief financial officer John Molina likes to say. Its knitting since its founding in 1980 by Molina's father, David Molina, has...
CNC: 69.08 (-0.59), ANTM: 154.45 (+0.25), UNH: 121.36 (-0.16), WCG: 78.78 (+0.04), AET: 111.45 (-0.86), HNT: 65.95 (-0.09), MOH: 68.33 (-0.24), HUM: 182.69 (-1.83)

Downgrade Alert for Centene (CNC)
Comtex SmarTrend(R) - Wed Jul 22, 7:29AM CDT
Centene (NYSE:CNC) was downgraded from Neutral to Sell at Goldman Sachs today. The stock closed yesterday at $71.78 on volume of 2.4 million shares, above average daily volume of 2.1 million. Centene (NYSE:CNC) has potential upside of 5.5% based on a current price of $71.78 and analysts' consensus price target of $75.75. Centene shares should encounter resistance at the 50-day moving average (MA) of $73.98 and support at its 200-day MA of $60.48.
CNC: 69.08 (-0.59)

After Yesterday's Decline of 3.78%, Centene Offers Investors Better Value
Comtex SmarTrend(R) - Tue Jul 21, 4:33PM CDT
Centene (NYSE:CNC) traded in a range yesterday that spanned from a low of $70.50 to a high of $72.85. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $73.25 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CNC: 69.08 (-0.59)

Stocks Hit By Weak Earnings; Tesla, Auto Stocks Fall
at Investor's Business Daily - Tue Jul 21, 3:22PM CDT
Stocks fell Tuesday, ending three sessions of broad-based gains, following weak earnings reports from market heavyweights IBM (IBM) and United Technologies (UTX). The Dow Jones industrial average dropped 1.0% as United Technologies and IBM lost 7%...
LAD: 116.89 (+4.30), TSLA: 264.56 (-0.26), HOG: 58.58 (+0.40), UTX: 98.20 (-0.77), PAG: 52.27 (+2.10), CNC: 69.08 (-0.59), KMX: 63.67 (+1.00), IBM: 161.07 (+1.02), ABG: 85.24 (+1.59), AN: 60.51 (+0.43)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Health Net, Inc. Regarding the Sale of the Company to Centene Corporation
Business Wire - Mon Jul 20, 4:20PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Health Net, Inc. (NYSE:HNT) ("Health Net" or "the Company" in connection with the sale of the Company to Centene Corporation (NYSE:CNC). Under the terms of the transaction, Health Net shareholders will receive 0.622 shares of Centene common stock and $28.25 in cash for each share of Health Net common stock they own.
CNC: 69.08 (-0.59), HNT: 65.95 (-0.09)

Newfound Market Strength Could Benefit These IBD 50 Names
at Investor's Business Daily - Fri Jul 17, 5:48PM CDT
The stock market often does what's least expected, and that certainly has been the case lately. Consider these four recent occurrences: A heavy distribution-day count for the Nasdaq and S&P 500 in recent weeks didn't do much damage to the market. In...
CNC: 69.08 (-0.59), AMBA: 117.73 (-1.53), MNST: 149.72 (-0.27), VRX: 253.96 (-3.99), ILMN: 215.19 (-2.63), RCPT: 227.87 (+0.71), HAWK: 44.52 (+0.40), FLTX: 46.89 (-0.54), REGN: 542.00 (-10.45), CELG: 132.88 (-2.54)

Bigger Is Better For Managed Care In ObamaCare Era
at Investor's Business Daily - Fri Jul 17, 3:02PM CDT
The Supreme Court's June 25 ruling to preserve ObamaCare exchange subsidies in 34 states using HealthCare.gov had the effect of a starter's pistol, shifting insurer consolidation into high gear. The immediate stakes in the case weren't dramatic for...
CI: 145.90 (+0.03), CNC: 69.08 (-0.59), ANTM: 154.45 (+0.25), CTRX: 61.47 (+0.04), UNH: 121.36 (-0.16), CVS: 113.36 (+1.72), AET: 111.45 (-0.86), HNT: 65.95 (-0.09), HUM: 182.69 (-1.83)


UnitedHealth tops Street 2Q forecasts, raises forecasts
By TOM MURPHY - AP - Thu Jul 16, 10:43AM CDT
UnitedHealth continued to juice up its business outside health insurance in a better-than-expected second quarter while rivals scrambled to add enrollment in a wave of mega-mergers sweeping the sector.
CNC: 69.08 (-0.59), CI: 145.90 (+0.03), ANTM: 154.45 (+0.25), CTRX: 61.47 (+0.04), ANTX: 50.81 (+0.10), UNH: 121.36 (-0.16), CCT.TO: 80.18 (+0.12), AET: 111.45 (-0.86), HUM: 182.69 (-1.83)

UnitedHealth Beats Q2 Earnings & Revenues; Raises Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 16, 9:30AM CDT
UnitedHealth's (UNH) reported second-quarter 2015 earnings of $1.64 per share, beating the Zacks Consensus Estimate of $1.57. Earnings soared 15.5% year over year.
CNC: 69.08 (-0.59), ANTM: 154.45 (+0.25), UNH: 121.36 (-0.16), SEM: 14.89 (+0.03)

Molina Healthcare Unit to Buy Medicaid Assets from Preferred - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 15, 4:00PM CDT
Molina Healthcare, Inc. (MOH) has entered into an agreement with Preferred Medical Plan, Inc. (Preferred) pertaining to the acquisition of certain assets of the latter.
CNC: 69.08 (-0.59), ANTM: 154.45 (+0.25), UNH: 121.36 (-0.16), MOH: 68.33 (-0.24)

2 Health Insurers Promising Earnings Beat in Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 15, 3:45PM CDT
The second quarter of 2015 saw frenzied mergers in the health insurance industry with players snapping up rivals to grow and remain competitive in a fast changing landscape.
CNC: 69.08 (-0.59), CI: 145.90 (+0.03), ANTM: 154.45 (+0.25), AET: 111.45 (-0.86), HNT: 65.95 (-0.09), HUM: 182.69 (-1.83)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 637

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 202

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 345

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 60

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 203

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 215

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 107

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Li Auto Inc. Reports Record Revenue and Milestone Deliveries

Updated Category News Views 89

Li Auto Inc. Announces Impressive Financial Results In the latest quarter, Li Auto Inc. reported a remarkable total revenue of RMB42.9 billion (approximately US$6.1 billion), showcasing a year-over-year growth of 23.6%. This impressive performance reflects the company's strong market presence and strategic execution. Quarterly Deliveries and Growth In terms of vehicle...

Continue Reading
LifeWallet's $2 Million Settlement and Strategic Progress Ahead

Updated Category News Views 162

LifeWallet's Recent Settlement Progress LifeWallet, formerly known as MSP Recovery, has recently made headlines by announcing a preliminary $2 million settlement as part of its portfolio of pharmaceutical litigation cases. This development is just one part of the company's broader strategy to engage various pharmaceutical and medical device manufacturers. The commitment...

Continue Reading
Revolutionary Approaches to Managing Resistant Hypertension

Updated Category News Views 261

Understanding Resistant Hypertension Resistant hypertension is a significant challenge for many patients, often referred to as the silent killer due to its insidious nature. Many individuals suffering from high blood pressure are unaware they have it, leading to severe health complications like cardiovascular disease over time. With the upcoming World Hypertension Day,...

Continue Reading
Understanding Wipro's Anticipated Earnings Performance

Updated Category News Views 51

Understanding Wipro's Anticipated Earnings Performance Wipro (WIT) is poised to release its latest quarterly earnings shortly. Investors are eager to gain insights from this upcoming report, which is shaping up to be a pivotal moment for the company. With analysts estimating an earnings per share (EPS) of $0.07, stakeholders are closely watching for news that could...

Continue Reading
Breakthrough Gene Therapy for Parkinson's Secures FDA Designation

Updated Category News Views 276

Significant FDA Recognition for AB-1005 AskBio Inc., known for its groundbreaking work in gene therapy, has made headlines with the announcement that its investigational gene therapy AB-1005 has received the esteemed Regenerative Medicine Advanced Therapy (RMAT) designation from the United States Food and Drug Administration (FDA). This acknowledgement comes on the heels...

Continue Reading